These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21441827)

  • 41. Patents and growth.
    Pentland AP; Connolly NL; Fahner-Vihtelic JE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1037-41. PubMed ID: 22330272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Bayh-Dole Act: a model for promoting research translation?
    Loewenberg S
    Mol Oncol; 2009 Apr; 3(2):91-3. PubMed ID: 19383372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating disparities in the U.S. technology transfer ecosystem to improve bench to business translation.
    Weis J; Bashyam A; Ekchian GJ; Paisner K; Vanderford NL
    F1000Res; 2018; 7():329. PubMed ID: 29721313
    [No Abstract]   [Full Text] [Related]  

  • 44. Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and business.
    Fernandes M; Miska D
    Biotechnol Genet Eng Rev; 2004; 21():249-76. PubMed ID: 17017036
    [No Abstract]   [Full Text] [Related]  

  • 45. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act.
    Berman EP
    Soc Stud Sci; 2008 Dec; 38(6):835-71. PubMed ID: 19227798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lessons from Bayh-Dole.
    Sampat BN
    Nature; 2010 Dec; 468(7325):755-6. PubMed ID: 21150971
    [No Abstract]   [Full Text] [Related]  

  • 47. Patents, innovation, and privatization: Commentary on: "Data management in academic settings: an intellectual property perspective".
    Albin RC
    Sci Eng Ethics; 2010 Dec; 16(4):777-81. PubMed ID: 20882419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can we expect to achieve anything from Indian Bayh Dole?
    Janodia MD; Sreedhar D; Ligade VS; Udupa N
    Indian J Med Res; 2009 Oct; 130(4):487. PubMed ID: 19942757
    [No Abstract]   [Full Text] [Related]  

  • 49. Global health equity in United Kingdom university research: a landscape of current policies and practices.
    Gotham D; Meldrum J; Nageshwaran V; Counts C; Kumari N; Martin M; Beattie B; Post N
    Health Res Policy Syst; 2016 Oct; 14(1):76. PubMed ID: 27724907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Faculty and employee ownership of inventions in Australia.
    McBratney A; Tarr JA
    Nat Biotechnol; 2010 Oct; 28(10):1019-22. PubMed ID: 20944586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulating scientific research: intellectual property rights and the norms of science.
    Rai AK
    Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815
    [No Abstract]   [Full Text] [Related]  

  • 52. Technology transfer: The leap to industry.
    Wapner J
    Nature; 2016 May; 533(7601):S13-5. PubMed ID: 27144603
    [No Abstract]   [Full Text] [Related]  

  • 53. From academic laboratory to the market: Disclosed and undisclosed narratives of commercialization.
    Sapir A; Oliver AL
    Soc Stud Sci; 2017 Feb; 47(1):33-52. PubMed ID: 28195026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patenting for the research scientist: an update.
    Crespi RS
    Trends Biotechnol; 2004 Dec; 22(12):638-42. PubMed ID: 15542154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of America Invents Act on Biotech Intellectual Property.
    Murphy A; Stramiello M; Stroud J; Lewis S; Irving T
    Cold Spring Harb Perspect Med; 2015 Apr; 5(9):a020784. PubMed ID: 25918182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Short Introduction to Intellectual Property Rights.
    Voss T; Paranjpe AS; Cook TG; Garrison NDW
    Tech Vasc Interv Radiol; 2017 Jun; 20(2):116-120. PubMed ID: 28673648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Commercialization: patenting and licensing in wound healing and regenerative biology.
    Hood WC; Huizenga D
    Methods Mol Biol; 2013; 1037():549-66. PubMed ID: 24029958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Technology Transfer: From the Research Bench to Commercialization: Part 2: The Commercialization Process.
    Van Norman GA; Eisenkot R
    JACC Basic Transl Sci; 2017 Apr; 2(2):197-208. PubMed ID: 30167567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Need a reagent? Just sign here..
    Marshall E
    Science; 1997 Oct; 278(5336):212-3. PubMed ID: 9340765
    [No Abstract]   [Full Text] [Related]  

  • 60. Patenting nanotechnology.
    Lemley MA
    Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.